ScienceMedia Launches SMi TrialD: The World’s First Mobile Education Platform for Decentralized Clinical Trials
Developed to minimize start-up timelines and ensure study integrity over the life of decentralized or hybrid trials, the pioneering SMi TrialD platform incorporates modules specifically designed to enhance the experience and contribution of patients and caregivers, home healthcare providers, investigative sites, and other study support roles. SMi TrialD’s content creators and writers have a collective 46 years of experience leading innovation in clinical trial support, including Product Director, Robert Geckeler, whose background in therapeutic development brings a hands-on user perspective to the platform’s focus.
Geckeler stated, “As clinical studies increasingly adopt a patient-centric approach and take advantage of remote tools to achieve protocol objectives, we at ScienceMedia saw an opportunity to leverage our cutting-edge delivery of study-related eLearning and tools to help this trial segment.”
The visionaries behind SMi TrialD have created an intuitive, highly secure, and scalable platform that delivers role-based education and training, just-in-time. SMi TrialD is truly the premier virtual and mobile platform for those looking to lead innovation in decentralized trials.
“We have been rallying to the call of hybrid trials for quite some time, and when COVID hit, we fast-tracked the development of SMi TrialD and I’m so proud to be the world’s first education and training platform to serve this growing trial environment,” said CEO, Mark Surles.
To learn more about how SMi TrialD is paving the way in serving decentralized trials, visit www.sciencemedia.com/decentralized.
For over 25 years, ScienceMedia has been at the forefront of delivering innovative, multimedia learning solutions aimed at improving clinical competency across all functional areas in the world's leading life science organizations. ScienceMedia draws on its expert team of clinical writers, instructional designers, and multimedia artists to produce training that has a real impact on reducing the highest risk areas of a clinical trial. SMi Trial mitigates clinical risk and decreases trial cost by optimizing study compliance throughout the lifetime of your clinical trial. SMi TrialD is the world’s first mobile education and training platform specifically for decentralized and hybrid trials. SMi Source is a mobile-enabled, cloud-based science education library that provides 16,000+ microlearning topics and 400+ full courses covering a vast catalog of disease and therapeutic areas. Learn more at sciencemedia.com.